NewsGlobeNewswire
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
· Published
Article summary
Oncolytics Biotech® Will Present REO 033 Trial in Progress Abstract at ESMO 2026 Showcasing Pelareorep’s Potential in Colorectal Cancer
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…